Wnt receptor Frizzled 8 is a target of ERG in prostate cancer-Reference-Cited by-同舟云学术

Wnt receptor Frizzled 8 is a target of ERG in prostate cancer

Published:2018-07-26 Issue:16 Volume:78 Page:1311-1320
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Chakravarthi Balabhadrapatruni V. S. K.¹²^ORCID,Chandrashekar Darshan S.¹²,Hodigere Balasubramanya Sai Akshaya¹²,Robinson Alyncia D.¹,Carskadon Shannon³,Rao Uttam⁴,Gordetsky Jennifer¹²,Manne Upender¹²,Netto George J.¹²,Sudarshan Sunil²⁵,Palanisamy Nallasivam³^ORCID,Varambally Sooryanarayana¹²^ORCID

Affiliation:

1. Department of Pathology; University of Alabama at Birmingham; Birmingham Alabama

2. Comprehensive Cancer Center; University of Alabama at Birmingham; Birmingham Alabama

3. Vattikuti Urology Institute; Department of Urology; Henry Ford Health System; Detroit Michigan

4. Department of Medicine; University of Alabama at Birmingham; Birmingham Alabama

5. Department of Urology; University of Alabama at Birmingham; Birmingham Alabama

Funder

National Cancer Institute

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.23704/fullpdf

Reference45 articles.

1. Genomic and epigenomic alterations in cancer;Chakravarthi;Am J Pathol,2016

2. Enzalutamide: a new agent for the prostate cancer treatment armamentarium;McCutcheon;J Adv Pract Oncol,2013

3. Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer;Semenas;Drug Des Devel Ther,2013

4. TMPRSS2-ERG fusion promotes prostate cancer metastases in bone;Deplus;Oncotarget,2017

5. Development of peptidomimetic inhibitors of the ERG gene fusion product in prostate cancer;Wang;Cancer Cell,2017

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico molecular docking, molecular dynamics, ADMET analysis of fucoidan against receptor frizzled-8 and coreceptor LRP6 in Wnt/β-Catenin pathway and in vitro analysis of fucoidan extract from Sargassum echinocarpum as β-catenin inhibitor in breast cancer cell line (MCF-7);Journal of Biomolecular Structure and Dynamics;2023-10-09

2. Wnt Signaling and Therapeutic Resistance in Castration-Resistant Prostate Cancer;Current Pharmacology Reports;2023-09-19

3. Chromosome 21;Cancer Genes: Volume 2;2023-08-16

4. Using cancer proteomics data to identify gene candidates for therapeutic targeting;Oncotarget;2023-05-04

5. Systematic Analysis of Cellular Signaling Pathways and Therapeutic Targets for SLC45A3:ERG Fusion-Positive Prostate Cancer;Journal of Personalized Medicine;2022-11-02